ACTRN12615001233516已完成不适用
Randomized trial of doxycycline and Microdacyn versus standard care for prevention of intra-operative wound contamination and postoperative infection in clean elective surgical procedures
Mr Philip Knight, Orthopaedic Surgeon,0 个研究点目标入组 200 人开始时间: 2015年11月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
入排标准
- 年龄范围
- 16 Years 至 o limit(—)
- 性别
- All
入选标准
- •Able to provide informed consent; willingness to take part.
- •To undergo a clean procedure in Orthopaedic (e.g. joint prosthesis, arthroscopy, tendon repair, internal fixation, laminectomy, spinal fusion) or pacemaker insertion surgery
- •During the period 9 November 2015 to 10 February 2016 (for shoulder procedures at Manuka St Hospital during the extended period of 9 November 2015 to 9 November 2016).
排除标准
- •Pregnancy or breastfeeding.
- •Past adverse reaction to Microdacyn, doxycycline, minicycline tetracycline, cephlasporins , severe penecillin reactions, or chloxhexadine.
- •Previous Clostridium difficile colitis.
- •Suspected current infection on the overlying skin or in the deep tissues at the operation site.
- •At least one dose of a systemic antibiotic in the 4 days before the start of the trial.
- •The operation site is covered by plaster of Paris or a dressing during the 3 days before the operation.
研究者
相似试验
进行中(未招募)
1 期
An allocation by random phase II/III trial of doxycycline in comparison to standard therapy in newly-diagnosed cardiac AL amyloidosis patients with bortezomib-based therapyight chain (AL) amyloidosis is a protein conformational disease, caused by a small bonemarrow plasma cell clone producing light chains (LCs) that undergo conformational changes,aggregate and deposit in tissues in the form of amyloid fibrils. This process causes dysfunctionof the organs involved and leads to death if not effectively treated.EUCTR2017-002210-31-DEAmyloid Center - Biotechnology Research Laboratories Policlinico San Matteo120
已完成
4 期
Doxycycline Prophylaxis at Vacuum Aspiration TrialEndometritisNCT00547170University of Pittsburgh1,000
进行中(未招募)
1 期
Treatment with doxycycline and tauroursodeoxycholic acid (Doxy/TUDCA) plus standard supportive therapy in cardiac amyloidosis caused by transthyretiCardiac amyloidosis caused by transthyretinMedDRA version: 20.0Level: PTClassification code 10007509Term: Cardiac amyloidosisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2017-001621-41-ITFONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO102
招募中
不适用
Randomised placebo-controlled trial of oral doxycycline to reduce recurrent trachomatous trichiasisPACTR201512001370307ondon School of Hygiene & Tropical Medicine1,000
招募中
3 期
Montelukast effect in acne treatmentIRCT20191013045092N1Shiraz University of Medical Sciences160
